Nowadays, antibody drugs are increasingly important for the pharmaceutical industry across the globe. Antibody drugs are important therapeutic biological products in the evolution of life-saving disease treatment. In the formulation of antibody drugs integrated research plan, Medicilon has in-depth communication with customers. The backbone of scientific research has combined the characteristics of each case with years of practical experience and technical accumulation, and carefully submitted high-quality experimental plans and results to customers.

Medicilon provides antibody drugs discovery, CMC research (API + formulation), pharmacodynamics research, PK study, safety evaluation and other services. As of the end of 2023, Medicilon has successfully assisted in the clinical approval of 32 antibody drugs and has multiple antibody projects under development.

Read More...

Download PDF